These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24644520)

  • 1. Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia.
    Ibrahim MI; Abdelrahim HE; Ab Rahman AF
    Pharm Pract (Granada); 2014 Jan; 12(1):372. PubMed ID: 24644520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of gentamicin in patients with bronchopneumonia: cost considerations and patient outcomes.
    Ahmed Abdelrahim HE; Ab Rahman AF; Mohamed Ibrahim MI
    Eurasian J Med; 2012 Apr; 44(1):1-5. PubMed ID: 25610196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in comparing treatment outcome from a prospective with that of a retrospective study: assessing the merit of gentamicin therapeutic drug monitoring in pediatric oncology.
    Ho KK; Thiessen JJ; Bryson SM; Greenberg ML; Einarson TR; Leson CL
    Ther Drug Monit; 1994 Jun; 16(3):238-47. PubMed ID: 8085278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring for gentamicin in Hospital Universiti Sains Malaysia.
    Ismail R; Sarriff A; Abdul Rahman AF
    Med J Malaysia; 1990 Mar; 45(1):57-64. PubMed ID: 2152070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of gentamicin: a 6-year follow-up audit.
    Ismail R; Haq AH; Azman M; Rahman AF
    J Clin Pharm Ther; 1997 Feb; 22(1):21-5. PubMed ID: 9292398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vancomycin therapeutic drug monitoring on patient care.
    Welty TE; Copa AK
    Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit.
    Al-Sulaiti FK; Alkhiyami D; Elmekaty EZI; Awaisu A; Kheir N; El-Zubair A; Al-Sulaiti HK
    J Pharm Policy Pract; 2024; 17(1):2375753. PubMed ID: 39011355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients.
    Hodiamont CJ; Janssen JM; de Jong MD; Mathôt RA; Juffermans NP; van Hest RM
    Ther Drug Monit; 2017 Oct; 39(5):522-530. PubMed ID: 28682925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs.
    Suryadevara M; Steidl KE; Probst LA; Shaw J
    J Pediatr Pharmacol Ther; 2012 Apr; 17(2):159-65. PubMed ID: 23118668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.
    van Lent-Evers NA; Mathôt RA; Geus WP; van Hout BA; Vinks AA
    Ther Drug Monit; 1999 Feb; 21(1):63-73. PubMed ID: 10051056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of therapeutic drug monitoring services in Malaysia.
    Ab Rahman AF; Ahmed Abdelrahim HE; Mohamed Ibrahim MI
    Saudi Pharm J; 2013 Jan; 21(1):19-24. PubMed ID: 23960816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients.
    Kim Y; Kim S; Park J; Lee H
    J Pers Med; 2022 Jan; 12(2):. PubMed ID: 35207653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea.
    Choi R; Woo HI; Park HD; Lee SY
    Infect Drug Resist; 2019; 12():2163-2173. PubMed ID: 31410036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.